The WHO guidelines motivate the adoption of those technologies, offered they can be validated to reveal equivalent or excellent general performance in comparison to traditional approaches. Manufacturers looking to put into practice these methods should present strong validation details to exhibit their equivalence to pharmacopoeial solutions